Beyond Air, Inc. (NASDAQ:XAIR – Get Free Report) CEO Robert Scott Goodman bought 34,722 shares of the stock in a transaction that occurred on Wednesday, July 29th. The shares were purchased at an average cost of $5.76 per share, with a total value of $199,998.72. Following the purchase, the chief executive officer directly owned 34,822 shares of the company’s stock, valued at $200,574.72. The trade was a 34,722.00% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website.
Beyond Air Stock Performance
Shares of XAIR opened at $5.28 on Friday. The company has a current ratio of 3.80, a quick ratio of 3.59 and a debt-to-equity ratio of 3.48. The firm’s fifty day simple moving average is $7.69 and its two-hundred day simple moving average is $14.21. Beyond Air, Inc. has a 12 month low of $5.02 and a 12 month high of $95.60. The stock has a market capitalization of $3.80 million, a P/E ratio of -0.06 and a beta of 0.22.
Beyond Air (NASDAQ:XAIR – Get Free Report) last announced its quarterly earnings data on Friday, June 26th. The company reported ($15.40) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($11.33) by ($4.07). Beyond Air had a negative net margin of 432.99% and a negative return on equity of 350.00%. The business had revenue of $1.91 million during the quarter, compared to analyst estimates of $2.30 million.
Analyst Upgrades and Downgrades
Get Our Latest Analysis on XAIR
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in XAIR. Osaic Holdings Inc. increased its position in shares of Beyond Air by 26.4% during the second quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock worth $29,000 after acquiring an additional 34,000 shares in the last quarter. Virtu Financial LLC bought a new position in Beyond Air in the 3rd quarter valued at about $48,000. Geode Capital Management LLC lifted its position in Beyond Air by 57.5% in the 4th quarter. Geode Capital Management LLC now owns 67,678 shares of the company’s stock valued at $49,000 after acquiring an additional 24,695 shares in the last quarter. Finally, Alyeska Investment Group L.P. acquired a new position in Beyond Air during the 3rd quarter valued at about $1,753,000. 31.50% of the stock is currently owned by institutional investors and hedge funds.
About Beyond Air
Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.
The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.
Featured Articles
- Five stocks we like better than Beyond Air
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Beyond Air Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyond Air and related companies with MarketBeat.com's FREE daily email newsletter.
